Assessing risk of nodal metastasis and relapse-free survival by CP-GEP (Merlin™ Test) in a single-center retrospective case series of stage pT1a-4b cN0M0 melanoma patients

• DOI: 10.1016/j.ejcskn.2025.100365
• Publication Date: 2025-04-03T08:51:43Z
• Authors: J.I. Kessels; L. Heyvaert; M. Vounckx; I. Dirven; C. Bertels; G. Leemans; R. Forsyth; J. Gutermuth; B. Caljon; B. Neyns